Background: Adult immunocompetent male C57Bl/6 mucopolysaccharidosis, type I (MPSI) mice develop aortic insufficiency (AI), dilated ascending aortas and decreased cardiac function, findings not observed in immune incompetent adult male NSG MPSI mice. We sought to determine why.

Methods: Cardiac ultrasound measurements of ascending aorta and left ventricular dimensions and Doppler interrogation for AI were performed in 6-month-old male B6 MPSI (N = 12), WT (N = 6), NSG MPSI (N = 8), NSG (N = 6) mice. Urinary glycosaminoglycans, RNA sequencing with quantitative PCR were performed and aortic pathology assessed by routine and immunohistochemical staining on subsets of murine aortas.

Results: Ascending aortic diameters were significantly greater, left ventricular function significantly decreased, and AI significantly more frequent in B6 MPSI mice compared to NSG MPSI mice (p < 0.0001, p = 0.008 and p = 0.02, respectively); NSG and B6 WT mice showed no changes. Urinary glycosaminoglycans were significantly greater in B6 and NSG MPSI mice and both were significantly elevated compared to WT controls (p = 0.003 and p < 0.0001, respectively). By RNA sequencing, all 11 components of the inflammasome pathway were upregulated in B6 MUT, but only Aim2 and Ctsb in NSG MUT mice and none in WT controls. Both B6 and NSG MUT mice demonstrated variably-severe intramural inflammation, vacuolated cells, elastin fragmentation and disarray, and intense glycosaminoglycans on histological staining. B6 MPSI mice demonstrated numerous medial MAC2+ macrophages and adventitial CD3+ T-cells while MAC2+ macrophages were sparse and CD3+ T-cells absent in NSG MPSI mice.

Conclusions: Aortic dilation, AI and decreased cardiac function occur in immunocompetent B6 MPSI male mice but not in immune incompetent NSG MPSI mice, unrelated to GAG excretion, upregulation of Ctsb, or routine histologic appearance. Upregulation of all components of the inflammasome pathway in B6 MUT, but not NSG MUT mice, and abundant medial MAC2 and adventitial CD3 infiltrates in B6, but not NSG, MPSI aortas differentiated the two strains. These results suggest that the innate and adaptive immune systems play a role in these cardiac findings which may be relevant to human MPSI.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109621PMC
http://dx.doi.org/10.1016/j.ymgme.2022.01.104DOI Listing

Publication Analysis

Top Keywords

mpsi mice
28
nsg mpsi
28
mpsi
13
mice
13
nsg
12
nsg mut
12
mut mice
12
innate adaptive
8
adaptive immune
8
immune systems
8

Similar Publications

Novel mechanisms of intestinal flora regulation in high-altitude hypoxia.

Heliyon

October 2024

Department of Gastroenterology, National Institution of Drug Clinical Trial, Guizhou Provincial People's Hospital, No.83, East Zhongshan Road, Guiyang, Guizhou, China.

Article Synopsis
  • This study examines how Firmicutes bacteria influence macrophage polarization and metabolism in response to intestinal injury due to high-altitude hypoxia.
  • Researchers utilized a mouse model and advanced techniques like single-cell transcriptome sequencing, proteomics, and metabolomics to analyze changes in intestinal health under hypoxic conditions.
  • Findings highlight the significance of HIF-1α and glycolysis in this process, suggesting that macrophage behavior and gut microbiota play crucial roles in managing tissue damage from low oxygen environments.
View Article and Find Full Text PDF

Anti-amyloid treatment is broadly effective in neuronopathic mucopolysaccharidoses and synergizes with gene therapy in MPS-IIIA.

Mol Ther

November 2024

CEINGE-Biotecnologie Avanzate Franco Salvatore, Via G. Salvatore, 486 Napoli, Italy; Dipartimento di Medicina Clinica e Chirurgia, Università Degli Studi di Napoli "Federico II" Via S. Pansini, 5, Napoli, Italy. Electronic address:

Mucopolysaccharidoses (MPSs) are childhood diseases caused by inherited deficiencies in glycosaminoglycan degradation. Most MPSs involve neurodegeneration, which to date is untreatable. Currently, most therapeutic strategies aim at correcting the primary genetic defect.

View Article and Find Full Text PDF

Developing targeted therapies for neuroblastoma by dissecting the effects of metabolic reprogramming on tumor microenvironments and progression.

Theranostics

July 2024

Department of Orthopedics, Wenzhou Third Clinical Institute Affiliated to Wenzhou Medical University, The Third Affiliated Hospital of Shanghai University, Wenzhou People's Hospital, Wenzhou, China, 325041.

Article Synopsis
  • Researchers discovered how changing the way cells use energy affects the progression of a type of cancer called neuroblastoma (NB).
  • They created a system to predict how severe the cancer is and what treatments would work best for different patients.
  • Two medicines, AZD7762 and etoposide, were found to be effective for two different types of NB, helping to slow the growth of tumors and make the mice live longer.
View Article and Find Full Text PDF

Background: We recently found that butyrate could ameliorate inflammation of alcoholic liver disease (ALD) in mice. However, the exact mechanism remains incompletely comprehended. Here, we examined the role of butyrate on ALD-associated inflammation through macrophage (Mψ) regulation and polarization using in vivo and in vitro experiments.

View Article and Find Full Text PDF

Mucopolysaccharidosis Type I (MPSI) is a rare inherited lysosomal storage disease that arises due to mutations in the IDUA gene. Defective alpha-L-iduronidase (IDUA) enzyme is unable to break down glucosaminoglycans (GAGs) within the lysosomes and, as a result, there is systemic accumulation of undegraded products in lysosomes throughout the body leading to multi-system disease. Here, we characterised the skeletal/craniofacial, neuromuscular and behavioural outcomes of the MPSI Idua-W392X mouse model.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!